A comparison of the lived experiences among extended and long-term young adult cancer survivors

Belgique Nouvelles Nouvelles

A comparison of the lived experiences among extended and long-term young adult cancer survivors
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 71%

A comparison of the lived experiences among extended and long-term young adult cancer survivors Nutrients_MDPI USouthFlorida cancer survivor cancersurvivor youngadult livedexperiences

By Neha MathurJul 18 2023Reviewed by Lily Ramsey, LLM In a recent qualitative study published in the Nutrients Journal, researchers compared the life experiences of young adult cancer survivors aged 18 to 39.

Background Compared to older adults, young adults with cancer experience unique challenges while navigating cancer treatment, which can worsen their quality of life. For instance, due to their age, they have more appearance-related concerns, specifically due to skin scarring and hair loss after receiving chemo- or radiotherapies for cancer treatment.

Related StoriesOther inclusion criteria were cancer diagnosis between 18 and 39 years of age, time elapsed since treatment completion was less than one-year OR three or more years, and ability to comprehend English. Results The team interviewed 24 YA participants, of which 12 were 'Extended,' and the other 12 were 'Long-term' survivors. 88%, 54%, and 83% of the participants were non-Hispanic, White, and female, respectively. The average interview duration was 41 minutes.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer - npj Breast CancerRAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer - npj Breast Cancernpj Breast Cancer - RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
Lire la suite »

Researchers demonstrate targeted epigenome editing in the promoter region of several genes using sgRNA/dCas9 complexesResearchers demonstrate targeted epigenome editing in the promoter region of several genes using sgRNA/dCas9 complexesResearchers demonstrate targeted epigenome editing in the promoter region of several genes using sgRNA/dCas9 complexes researchsquare Uni_Stuttgart CRISPR geneediting genetics epigenome epigenetics
Lire la suite »

Predicting kidney abnormalities in utero with deep learningPredicting kidney abnormalities in utero with deep learningPredicting kidney abnormalities in utero with deep learning OttawaHospital uOttawa kidney health deeplearning
Lire la suite »

Unveiling long COVID: new study explores symptoms and strain variationsUnveiling long COVID: new study explores symptoms and strain variationsUnveiling long COVID: new study explores symptoms and strain variations Life_MDPI longcovid covid COVID19 SARSCoV2 longCOVID symptoms strain
Lire la suite »

Unraveling the consequences: COVID-19's devastating effect on the TB care cascadeUnraveling the consequences: COVID-19's devastating effect on the TB care cascadeUnraveling the consequences: COVID-19's devastating effect on the TB care cascade medrxivpreprint StellenboschUni covid COVID19 SARSCoV2 TB tuberculosis healthequity LMICs
Lire la suite »

Touching lives: understanding factors for successful touch interventionsTouching lives: understanding factors for successful touch interventionsTouching lives: understanding factors for successful touch interventions medrxivpreprint touchintervention touch mentalhealth physicalhealth research
Lire la suite »



Render Time: 2025-04-12 21:53:37